Retinitis pigmentosa: visual function and multidisciplinary management
- PMID: 16255692
- DOI: 10.1111/j.1444-0938.2005.tb06717.x
Retinitis pigmentosa: visual function and multidisciplinary management
Abstract
Retinitis pigmentosa (RP) is a leading cause of blindness and visual disability in younger people. Optometrists have a major role in detecting RP and in reducing the visual disability associated with RP. This review summarises the literature relating to visual function in people with RP, with particular attention given to night-blindness, visual acuity decrease and visual field contraction. The range of low vision aids available for people with RP is reviewed and suggestions given on aids that have been found to be most successful. Most importantly, this review overviews the range of services available to people with RP and emphasises how optometrists need to work with a network of professionals to ensure the best possible visual outcomes for people with RP. Particular mention is made of current findings relating to orientation and mobility training, driving, sensory substitution and adaptive technology. The modern optometrist needs to be aware of the multiple needs of people with RP and have the ability to link them with the professionals best able to help them.
Similar articles
-
Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.Ophthalmology. 2016 May;123(5):1151-60. doi: 10.1016/j.ophtha.2016.01.021. Epub 2016 Feb 27. Ophthalmology. 2016. PMID: 26927203
-
Sector retinitis pigmentosa.Optometry. 2005 May;76(5):309-17. doi: 10.1016/s1529-1839(05)70314-6. Optometry. 2005. PMID: 15884421
-
Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):893-908. doi: 10.1007/s00417-018-3953-5. Epub 2018 Mar 15. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29546474 Clinical Trial.
-
Review and update: current treatment trends for patients with retinitis pigmentosa.Optometry. 2009 Jul;80(7):384-401. doi: 10.1016/j.optm.2008.01.026. Optometry. 2009. PMID: 19545852 Review.
-
[Research progress of treatment strategies for retinitis pigmentosa].Zhonghua Yan Ke Za Zhi. 2017 Feb 11;53(2):148-153. doi: 10.3760/cma.j.issn.0412-4081.2017.02.015. Zhonghua Yan Ke Za Zhi. 2017. PMID: 28260368 Review. Chinese.
Cited by
-
Short-Wavelength Light-Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial.JMIR Res Protoc. 2023 Nov 16;12:e49196. doi: 10.2196/49196. JMIR Res Protoc. 2023. PMID: 37971796 Free PMC article.
-
Full-field, conformal epiretinal electrode array using hydrogel and polymer hybrid technology.Sci Rep. 2023 Apr 28;13(1):6973. doi: 10.1038/s41598-023-32976-9. Sci Rep. 2023. PMID: 37117214 Free PMC article.
-
Optical coherence tomography in healthy human subjects in the setting of prolonged dark adaptation.Sci Rep. 2023 Mar 6;13(1):3725. doi: 10.1038/s41598-023-30747-0. Sci Rep. 2023. PMID: 36879027 Free PMC article.
-
Current and Future Treatment of Retinitis Pigmentosa.Clin Ophthalmol. 2022 Aug 31;16:2909-2921. doi: 10.2147/OPTH.S370032. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36071725 Free PMC article.
-
Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs.Clin Ophthalmol. 2022 Jun 20;16:1993-2010. doi: 10.2147/OPTH.S365486. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35757022 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
